KFDA Updates X-ray Metrology Device Registration Rules

On May 16, 2026, the Korean Ministry of Food and Drug Safety (MFDS, formerly KFDA) issued the Guidance for Registration of X-ray Metrology Devices for Medical Use (2026 Revision), mandating that laser interferometric compensation modules be declared as independent functional units — with distinct model numbers, manufacturers, and NIST-traceable calibration certificates. This update directly affects manufacturers, exporters, and importers of precision X-ray metrology equipment targeting the Korean medical device market.

Event Overview

On May 16, 2026, the Korean Ministry of Food and Drug Safety (MFDS) published the Guidance for Registration of X-ray Metrology Devices for Medical Use (2026 Revision). The revision explicitly requires that any laser interferometric compensation module integrated into an X-ray metrology device must be listed separately in registration submissions, including its specific model number, manufacturer name, and a valid NIST-traceable calibration certificate. As confirmed by customs reports, this change has led to the temporary detention of multiple shipments of Chinese-made X-ray metrology devices at Incheon International Airport, pending submission of corrected documentation.

Industries Affected

Direct Exporters and Trade Enterprises

Exporters of X-ray metrology systems to Korea are immediately affected because registration dossiers must now disaggregate subsystems previously treated as integral components. The requirement introduces new technical documentation burdens and delays approval timelines if modules lack independently verifiable calibration evidence.

Equipment Manufacturers (OEMs and System Integrators)

Manufacturers embedding third-party or proprietary laser interferometric compensation modules must now ensure each module carries its own certified traceability documentation. This impacts product labeling, technical file architecture, and internal quality record-keeping — particularly where modules are sourced from suppliers without NIST-aligned calibration workflows.

Supply Chain and Regulatory Support Providers

Regulatory consultants, local representatives (Korean Authorized Representatives), and logistics service providers handling MFDS submissions face revised scope-of-work expectations. Supporting documentation must now include module-level verification, increasing review time and coordination complexity across engineering, QA, and regulatory teams.

What Relevant Enterprises or Practitioners Should Focus On and How to Respond

Monitor Official Clarifications and Implementation Timelines

Analysis shows that the guidance does not specify a grace period or transitional provisions. Enterprises should track official announcements from MFDS and Korean Notified Bodies for confirmation on enforcement start dates and acceptable formats for calibration certificates.

Verify Module-Level Documentation for Active and Pipeline Submissions

Current more appropriate action is to audit all X-ray metrology devices intended for Korean registration — especially those containing laser interferometric compensation modules — to confirm whether model-specific calibration certificates exist and whether they meet NIST traceability requirements as defined in ISO/IEC 17025 or ANSI/NCSL Z540.

Engage Module Suppliers Early to Align on Certification Requirements

Observably, many laser interferometric modules are procured from specialized optomechanical vendors who may not routinely issue NIST-traceable certificates. Firms should initiate supplier communications now to assess capability, lead times, and potential re-certification needs before resubmitting or filing new applications.

Update Internal Technical Files and Labeling Practices

From industry perspective, the revision signals a broader shift toward granular subsystem accountability in Korean medical device regulation. Companies should revise internal design history files, labeling templates, and EUA/MFDS submission checklists to reflect mandatory module-level identification and documentation.

Editorial Perspective / Industry Observation

This update is better understood as a regulatory signal — rather than an isolated procedural change — indicating MFDS’s increasing emphasis on metrological integrity in diagnostic-grade measurement tools. Analysis shows it aligns with global trends toward component-level traceability in high-precision medical instrumentation, but diverges from current EU MDR or US FDA approaches, which typically treat such modules as part of the overall system performance validation. Observably, the airport detentions suggest enforcement is already active, meaning the policy has moved beyond signaling into operational impact. Industry should therefore treat this as both a near-term compliance priority and a marker of evolving Korean expectations for measurement assurance in regulated health technologies.

Conclusion
This regulatory update underscores the growing importance of metrological traceability as a discrete compliance criterion — not just a quality attribute — in Korea’s medical device registration process. It does not represent a broad classification change or new risk category, but rather a tightening of evidentiary requirements for a specific functional unit within an established device type. Current more appropriate understanding is that this reflects targeted enforcement maturity, not a systemic overhaul; firms should prioritize documentation alignment over strategic redirection.

Information Sources
Main source: Korean Ministry of Food and Drug Safety (MFDS), Guidance for Registration of X-ray Metrology Devices for Medical Use (2026 Revision), published May 16, 2026.
Note: Ongoing observation is required regarding MFDS’s interpretation of ‘NIST-traceable’ for non-U.S.-based calibration labs and whether equivalency pathways (e.g., via APAC MRA signatories) will be accepted.